Arcus Biosciences Inc (RCUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 150,000 | 127,000 | 206,000 | 148,000 | 173,415 |
| Marketable Securities | 828,000 | 632,000 | 803,000 | 351,000 | 555,231 |
| Receivables | 20,000 | 38,000 | 39,000 | 745,000 | 1,698 |
| TOTAL | $1,016,000 | $831,000 | $1,067,000 | $1,262,000 | $735,815 |
| Non-Current Assets | |||||
| PPE Net | 47,000 | 51,000 | 35,000 | 32,000 | 10,807 |
| Investments And Advances | 14,000 | 107,000 | 129,000 | 182,000 | 6,440 |
| Other Non-Current Assets | 73,000 | 106,000 | 114,000 | 116,000 | 19,230 |
| TOTAL | $134,000 | $264,000 | $278,000 | $330,000 | $36,477 |
| Total Assets | $1,150,000 | $1,095,000 | $1,345,000 | $1,592,000 | $772,292 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 18,000 | 17,000 | 20,000 | 10,000 | 15,682 |
| Accrued Expenses | N/A | N/A | N/A | N/A | 27,850 |
| Other current liabilities | 123,000 | 76,000 | 76,000 | 54,000 | 3,566 |
| TOTAL | $226,000 | $184,000 | $193,000 | $166,000 | $121,669 |
| Non-Current Liabilities | |||||
| Long Term Debt | 48,000 | N/A | N/A | N/A | N/A |
| Deferred Revenues | 85,000 | 91,000 | 97,000 | 102,000 | 74,571 |
| Other Non-Current Liabilities | 157,000 | 142,000 | 140,000 | 122,000 | 15,786 |
| TOTAL | $439,000 | $449,000 | $495,000 | $584,000 | $148,319 |
| Total Liabilities | $665,000 | $633,000 | $688,000 | $750,000 | $269,988 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 105,841 | 90,865 | 73,011 | 71,062 | 70,876 |
| Common Shares | 1,617,000 | 1,311,000 | 1,206,000 | 1,118,000 | 6 |
| Retained earnings | -1,132,000 | -849,000 | -542,000 | -275,000 | -328,184 |
| Other shareholders' equity | 0 | 0 | -7,000 | -1,000 | 44 |
| TOTAL | $485,000 | $462,000 | $657,000 | $842,000 | $502,304 |
| Total Liabilities And Equity | $1,150,000 | $1,095,000 | $1,345,000 | $1,592,000 | $772,292 |